Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.36 | N/A | -0.51% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.36 | N/A | -0.51% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed a cautious optimism about future growth. They emphasized their commitment to innovation while acknowledging market challenges.
Management highlighted ongoing investments in innovation and R&D.
They noted a strong demand in key markets despite economic uncertainties.
Agilent Technologies reported an EPS of $1.36, slightly missing expectations. Despite this, the stock saw a modest increase of 0.26%, likely driven by positive commentary on future investments and demand in key markets. Investors may be encouraged by the company's focus on innovation, even in a challenging economic environment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
DIAMONDBACK ENERGY I
Feb 23, 2026